Nuclear Imaging

Molecular Imaging

Nuclear Imaging

Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m filtered sulfur colloid when undergoing lymphoscintigraphy, a functional imaging techni...

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). 

GE Healthcare received U.S. Food and Drug Administration (FDA) 510(k) clearance of its Q.Clear technology, which is designed to provide up to two times improvement in both quantitative accuracy and image quality in PET/CT imaging. 

New quantitative data suggests that 30 percent of the surgeries performed for non-small cell lung cancer patients in a community-wide clinical study were deemed unnecessary. 

F-18 Flutemetamol PET Alzheimer’s Association Intl. Conference 2014 Study
New study data presented at the Alzheimer’s Association Intl. Conference 2014 (AAIC) showed that a positive [18F]flutemetamol positron emission tomography (PET...
July 22, 2014 — NorthStar Medical Radioisotopes broke ground on a new 50,000-square-foot facility in Beloit, Wis. When completed in late 2014, the...
July 8, 2014 — NorthStar Medical Radioisotopes LLC has signed a pledge with the Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty...
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recently held its annual meeting in St. Louis. It provided an in-depth review of molecular...
Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept) injection is a radioactive diagnostic imaging agent, approved by the
Siemens Healthcare's syngo.via for molecular imaging is a reading solution that transforms large amounts of data into comprehensive results...
GE Healthcare's Discovery* IQ^ PET/CT (positron emission tomography/computed tomography) system enable both outstanding image quality and...

Articles

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recently held its annual meeting in St. Louis. It provided an in-depth review of molecular...
A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients’ chances...
Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m...
A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients’ chances...

Video Center

The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
4 days 15 hours ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
3 weeks 5 days ago
Call-backs have always been a problem in mammography. They are a source of worry, added discomfort...
4 weeks 5 days ago
This webinar will allow clinicians to learn more about the breast imaging application available with GE Healthcare's unified Web-based viewer. Available...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
spectral mammography
During this webinar, Lydia Liao,  M.D., Ph.D., M.P.H., presented an overview of contrast-enhanced spectral mammography technology...